Skip to main content

5000 British adults to take part in cannabis trial - The Times

5000 British adults to take part in cannabis trial - The Times

Thousands of Britons will be given cannabis for pain relief in a clinical trial that could pave the way for millions to get the drug on the NHS.

Medical regulators have approved the UK’s first trial of pure cannabis for people with chronic pain caused by conditions including arthritis, The Times can reveal.

Some 5,000 adults will take vaporised cannabis daily for at least a year through inhalers that dispense cartridges containing a measured dose of “whole flower” unprocessed marijuana.

The participants will be compared with a control group of 5,000 adults of similar age, sex and health receiving standard pain care, to see if cannabis leads to a significant reduction in pain.

This data will be assessed by the National Institute for Health and

Adblock test (Why?)



https://www.thetimes.co.uk/article/5-000...-x6m9cg03w

Popular posts from this blog

Martha Stewart launches CBD line in crowded market - CNN

Martha Stewart launches CBD line in crowded market - CNN The hemp-derived, cannabidiol-rich gummies, soft gels and oil drops officially launched on Thursday after more than a year in development. The products are the result of the style maven's partnership with Canopy Growth ( CGC ) , the Canadian cannabis company with a multibillion-dollar backer in US alcohol giant Constellation Brands ( STZ ) . Stewart joined Canopy as an adviser in early 2019 for the express purpose of developing cannabis products for humans and their pets after being introduced to Canopy's founder by her friend Calvin Broadus Jr. -- the rapper and businessman better known as Snoop Dogg. His Leafs by Snoop cannabis brand is produced by Canopy. The initial Martha Stewart CBD products, which range from $34.99 to $44.99, will be sold online at Canopy's e-commerce site . The pet products are expected to debut later this year. "I was surprised to learn that while most people have heard of ...
Read more

The Half-Legal Cannabis Trap - POLITICO

The Half-Legal Cannabis Trap - POLITICO LOS ANGELES — Everything about Kelvin’s job in a neighborhood southwest of downtown seemed like any other assignment, if not a little more exciting. The 40-year-old, who had previously worked as an electrician, had been employed since 2015 by a private security company that contracted him out to guard marijuana dispensaries. In 2019, he was protecting one of the thousand or so cannabis stores in California’s biggest city—part of an industry that has grown less and less underground since 1996, when the state first legalized medical marijuana. Kelvin, who asked not to be identified beyond his middle name to avoid professional retaliation, doesn’t smoke pot, but says the gig felt like the future. He grew up in a time when other Black people he knew in Los Angeles would go to jail for possessing even small amounts of the drug. Now, customers could walk into shops like the one he was guarding, many of which can be identified by green crosses on...
Read more

Cannabis news worldwide -- Some Indian farmers are turning moon-gazers

Some Indian farmers are turning moon-gazers A growing number of cultivators opt for biodynamic techniques to give farming a zodiac twist Sarvdaman Patel , 69, stands between rows of legumes and parsley at high noon, but it is not the harsh sun that bothers him. He is obsessed with the moon. "It is currently in the Air sign which is ideal for flowering plants," he remarks, peering at the marigolds. Patel is no Bejan Daruwala. He is an Indian farmer who has been using biodynamic (BD) techniques for the last 16 years on his farm in Gujarat's Anand. The BD cultivation calendar is based on the moon's movement through each zodiac every two-and-a-half days covering all 12 signs every month. An unofficial estimate by the Biodynamic Association of India (BDAI) says about one lakh farmers in Maharashtra, Andhra Pradesh, Punjab and Uttarakhand practise biodynamic farming. However, most of the produce is sold under the generic 'organic' label as few consumers unde...
Read more